Schedule 13G Filing for Phathom Pharmaceuticals, Inc.

Millennium Management LLC, along with Millennium Group Management LLC and Israel A. Englander, has filed a Schedule 13G, indicating a 5.3% ownership in Phathom Pharmaceuticals, Inc. As of March 6, 2026, the total number of shares beneficially owned is 4,178,411. The filing confirms that these securities were not acquired or held for the purpose of changing or influencing the control of the issuer. The reporting persons, Millennium Management LLC and Millennium Group Management LLC, are both Delaware entities, while Israel A. Englander is a U.S. citizen. The principal business office for both LLCs and Mr. Englander is located at 399 Park Avenue, New York, New York 10022. A joint filing agreement between the parties is included as Exhibit I.